Onkológia 2/2017
Health technology assessment and value for money in drug policy
Health Technology Assessment or HTA is currently the major challenge in appraisal of medical innovations and healthcare systems. An article defines simplified, but holistic view on HTA and its application on innovations value creation and utilization, with respect to recent discussion on „value for money“.
Keywords: health technology assessment, value for money, drug policy
